Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LMACU
2501
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
| $6.75M | ﹤0.01% |
653,057
-46,124
| -7% | -$484K |
|
2502
Kearny Financial
KRNY
$604M
| $6.74M | ﹤0.01% |
542,323
-178,453
| -25% | -$2.2M |
|
2503
Fate Therapeutics
FATE
$286M
| $6.73M | ﹤0.01% |
113,561
-53,973
| -32% | -$4.23M |
|
2504
Coca-Cola Femsa
KOF
$22.7B
| $6.72M | ﹤0.01% |
119,436
-43,583
| -27% | -$2.44M |
|
2505
Aflac
AFL
$64.9B
| $6.72M | ﹤0.01% |
128,846
+53,268
| +70% | +$2.91M |
|
2506
Insperity
NSP
$1.93B
| $6.71M | ﹤0.01% |
60,606
-7,721
| -11% | -$793K |
|
|
EPHY
2507
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
| $6.69M | ﹤0.01% |
684,459
-1,027,300
| -60% | -$9.97M |
|
2508
Relmada Therapeutics
RLMD
$557M
| $6.67M | ﹤0.01% |
254,580
+238,351
| +1,469% | +$6.38M |
|
2509
Murphy Oil
MUR
$5.7B
| $6.67M | ﹤0.01% |
267,095
-24,543
| -8% | -$529K |
|
2510
PUT
Carvana
CVNA
$68.6B
| $6.66M | ﹤0.01% |
110,500
+47,000
| +74% | +$3.13M |
|
|
POSH
2511
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $6.66M | ﹤0.01% |
+280,243
| New | +$8.98M |
|
|
ENIA
2512
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $6.65M | ﹤0.01% |
1,137,364
-60,584
| -5% | -$406K |
|
|
GTPA
2513
DELISTED
Gores Technology Partners, Inc. Class A Common Stock
GTPA
| $6.65M | ﹤0.01% |
677,030
+56,539
| +9% | +$554K |
|
2514
Pricesmart
PSMT
$5.98B
| $6.64M | ﹤0.01% |
85,692
+81,051
| +1,746% | +$6.88M |
|
|
PSTX
2515
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $6.63M | ﹤0.01% |
909,856
-136,267
| -13% | -$1.17M |
|
|
GLS
2516
DELISTED
Gelesis Holdings, Inc.
GLS
| $6.63M | ﹤0.01% |
668,200
+214,778
| +47% | +$2.12M |
|
|
SAGE
2517
DELISTED
Sage Therapeutics
SAGE
| $6.63M | ﹤0.01% |
149,568
+79,583
| +114% | +$3.65M |
|
2518
Sempra
SRE
$57.9B
| $6.62M | ﹤0.01% |
104,616
+74,236
| +244% | +$4.9M |
|
|
KAIRU
2519
DELISTED
Kairos Acquisition Corp. Unit
KAIRU
| $6.6M | ﹤0.01% |
658,000
| – | – |
|
|
AIRC
2520
DELISTED
Apartment Income REIT Corp.
AIRC
| $6.6M | ﹤0.01% |
135,165
+93,262
| +223% | +$4.72M |
|
2521
Grindr
GRND
$3.08B
| $6.6M | ﹤0.01% |
651,087
| – | – |
|
|
X
2522
PUT
DELISTED
US Steel
X
| $6.59M | ﹤0.01% |
300,000
| – | – |
|
2523
TransAlta
TAC
$3.95B
| $6.59M | ﹤0.01% |
623,431
+523,171
| +522% | +$5.24M |
|
|
AGC
2524
DELISTED
Altimeter Growth Corp
AGC
| $6.59M | ﹤0.01% |
644,754
+439,502
| +214% | +$4.69M |
|
2525
STAAR Surgical
STAA
$1.21B
| $6.58M | ﹤0.01% |
51,198
+42,082
| +462% | +$5.89M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.